All patients (n = 130) | MAKE (n = 41) | No MAKE (n = 89) | p Value | |
---|---|---|---|---|
Kidney aggression factors within 7 days, n (%) | ||||
Aminoglycoside | 5 (3.9) | 5 (12.2) | 0 (0) | 0.0026 |
Hydroxocobalamin | 24 (18.5) | 14 (34.1) | 10 (11.2) | 0.0031 |
Shock (use of catecholamine) | 58 (44.6) | 34 (82.9) | 24 (27) | <0.0001 |
AKI within 7 days, n (%) | 73 (56.1) | 39 (95.1) | 34 (38.2) | <0.0001 |
KDIGO stage of patients with AKI within 7 days | 2 (1–3) | 3 (2–3) | 1 (1–2) | <0.0001 |
Serum creatinine, μmol/L | ||||
Admission | 67 (54–90) | 88 (67–118) | 64 (54–77) | <0.0001 |
Maximum within 7 days | 80 (65–113) | 135 (85–206) | 74 (64–86) | <0.0001 |
ICU discharge (alive, without RRT) | 49 (35–63) | 64 (43–85) | 49 (35–61) | 0.07 |
Oliguria within 7 days, n (%) | 63 (48.5) | 35 (85.4) | 28 (31.5) | <0.0001 |
RRT n (%) | ||||
Within 7 days | 18 (13.8) | 18 (44) | 0 (0) | <0.0001 |
During ICU stay | 26 (20) | 26 (63.4) | 0 (0) | <0.001 |
Alive at ICU discharge | 1 (0) | 1 (2.4) | – |